Lindus Health is set to partner with the Clinical Data Interchange Standards Consortium (CDISC) to leverage AI in accelerating the development of standardised biomedical concepts for clinical ...

Digital biomarker to enhance precision, reduce patient burden and boost efficiency of global Phase 2 trial of NEU-411 in early Parkinson’s disease November 19, 2024 07:30 AM Eastern Standard Time ...

Neuron23 is using a Roche-developed digital biomarker as the primary endpoint in the Phase 2 NEULARK trial of NEU-411 in early Parkinson’s disease.